Dr. Wai-Lung Ng completed his Ph.D. in organic chemistry at the Chinese University of Hong Kong (CUHK), under the supervision of Prof. Tony K. M. Shing. His Ph.D. studies centers on the syntheses of a new class of antidiabetic agents, namely sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. His research works have already led to the discovery of a stable, potent and selective SGLT2 inhibitor. With the generous funding supports from the Lee Hysan Foundation and the Fulbright Program, he researched on transition metal-catalyzed reactions as a Fulbright Scholar at MIT, working under the guidance of Prof. Stephen L. Buchwald. Starting from October 2014, he has been working in the Ben Davis group as a Croucher Foundation Postdoctoral Fellow. He is currently researching in the field of chemical biology and protein chemistry, with the aim of understanding the molecular basis of epigenetics regulation. Wai-Lung is also known as Billy in the group, and he is currently one of the lab managers based at ICL. You may click here to find out more information about him. email: wai.ng@chem.ox.ac.uk.

Last updated: 05-03-16